loadpatents
Patent applications and USPTO patent grants for KAROW; Margaret.The latest application filed is for "masked cytokine polypeptides".
Patent | Date |
---|---|
Masked Cytokine Polypeptides App 20220306716 - KAROW; Margaret ;   et al. | 2022-09-29 |
High affinity antibodies to human IL-6 receptor Grant 11,370,843 - Stevens , et al. June 28, 2 | 2022-06-28 |
Humanized universal light chain mice Grant 11,357,217 - McWhirter , et al. June 14, 2 | 2022-06-14 |
Activatable Masked Anti-ctla4 Binding Proteins App 20220073613 - Williams; John C. ;   et al. | 2022-03-10 |
Anti-ctla4 Antibodies And Methods Of Use Thereof App 20220064301 - Karow; Margaret | 2022-03-03 |
Masked Cytokine Polypeptides App 20220002370 - KAROW; Margaret ;   et al. | 2022-01-06 |
Trispecific T cell Engagers App 20210269551 - Karow; Margaret ;   et al. | 2021-09-02 |
Antitumor Antagonists App 20210246214 - SHENG; Jackie ;   et al. | 2021-08-12 |
Bispecific T cell Engagers App 20210246222 - Karow; Margaret ;   et al. | 2021-08-12 |
Masked cytokine polypeptides Grant 11,053,294 - Karow , et al. July 6, 2 | 2021-07-06 |
Antitumor antagonists Grant 11,001,635 - Sheng , et al. May 11, 2 | 2021-05-11 |
Adam6 Mice App 20210105984 - Macdonald; Lynn ;   et al. | 2021-04-15 |
Adam6 Mice App 20210105985 - Macdonald; Lynn ;   et al. | 2021-04-15 |
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20210094997 - GAVIN; Marc Alain ;   et al. | 2021-04-01 |
ADAM6 mice Grant 10,905,109 - Macdonald , et al. February 2, 2 | 2021-02-02 |
ADAM6 mice Grant 10,905,108 - Macdonald , et al. February 2, 2 | 2021-02-02 |
High Affinity Antibodies To Human Il-6 Receptor App 20210009698 - Stevens; Sean ;   et al. | 2021-01-14 |
Antagonists Targeting The Tgf-b Pathway App 20210002348 - Karow; Margaret ;   et al. | 2021-01-07 |
Masked Cytokine Polypeptides App 20210002343 - KAROW; Margaret ;   et al. | 2021-01-07 |
Antagonists targeting the TGF-.beta. pathway Grant 10,851,157 - Karow , et al. December 1, 2 | 2020-12-01 |
Interleukin-2 muteins for the expansion of T-regulatory cells Grant 10,829,535 - Gavin , et al. November 10, 2 | 2020-11-10 |
Humanized Non-human Animals With Restricted Immunoglobulin Heavy Chain Loci App 20200281175 - Macdonald; Lynn ;   et al. | 2020-09-10 |
Antagonists Targeting The Tgf-b Pathway App 20200231665 - KAROW; Margaret ;   et al. | 2020-07-23 |
ADAM6 mice Grant 10,694,725 - Macdonald , et al. | 2020-06-30 |
Antitumor Immune Checkpoint Regulator Antagonists App 20200181272 - SHENG; Jackie ;   et al. | 2020-06-11 |
Mice that produce hybrid antibodies Grant 10,640,800 - Murphy , et al. | 2020-05-05 |
Humanized Non-human Animals With Restricted Immunoglobulin Heavy Chain Loci App 20200093106 - Macdonald; Lynn ;   et al. | 2020-03-26 |
Antitumor immune checkpoint regulator antagonists Grant 10,597,453 - Sheng , et al. | 2020-03-24 |
Mice that produce hybrid antibodies Grant 10,584,364 - Murphy , et al. | 2020-03-10 |
Nucleic acids encoding high affinity antibodies to human IL-6 receptor Grant 10,584,173 - Stevens , et al. | 2020-03-10 |
ADAM6 mice Grant 10,577,430 - Macdonald , et al. | 2020-03-03 |
Humanized non-human animals with restricted immunoglobulin heavy chain loci Grant 10,542,735 - Macdonald , et al. Ja | 2020-01-28 |
Genetically modified mice that produce hybrid antibodies Grant 10,526,630 - Murphy , et al. J | 2020-01-07 |
Antitumor Immune Checkpoint Regulator Antagonists App 20200002417 - SHENG; Jackie ;   et al. | 2020-01-02 |
Antitumor Antagonists App 20200002426 - SHENG; Jackie ;   et al. | 2020-01-02 |
High Affinity Antibodies To Human Il-6 Receptor App 20190256606 - Stevens; Sean ;   et al. | 2019-08-22 |
Mice that produce hybrid antibodies Grant 10,378,038 - Murphy , et al. A | 2019-08-13 |
Methods of making a nucleic acid encoding a human variable region Grant 10,378,037 - Murphy , et al. A | 2019-08-13 |
Mice that produce hybrid antibodies Grant 10,378,040 - Murphy , et al. A | 2019-08-13 |
Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus Grant 10,378,039 - Murphy , et al. A | 2019-08-13 |
Humanized Universal Light Chain Mice App 20190133094 - McWhirter; John ;   et al. | 2019-05-09 |
Methods of modifying eukaryotic cells Grant 10,227,625 - Murphy , et al. | 2019-03-12 |
Adam6 Mice App 20180362663 - Macdonald; Lynn ;   et al. | 2018-12-20 |
Adam6 Mice App 20180346598 - Macdonald; Lynn ;   et al. | 2018-12-06 |
Adam6 Mice App 20180345760 - Macdonald; Lynn ;   et al. | 2018-12-06 |
Adam6 Mice App 20180346599 - Macdonald; Lynn ;   et al. | 2018-12-06 |
Humanized universal light chain mice Grant 10,130,081 - McWhirter , et al. November 20, 2 | 2018-11-20 |
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20180319859 - GAVIN; Marc A. ;   et al. | 2018-11-08 |
ADAM6 mice Grant 10,072,095 - Macdonald , et al. September 11, 2 | 2018-09-11 |
Interleukin-2 muteins for the expansion of T-regulatory cells Grant 9,932,380 - Gavin , et al. April 3, 2 | 2018-04-03 |
High affinity antibodies to human IL-6 receptor Grant 9,884,916 - Stevens , et al. February 6, 2 | 2018-02-06 |
Methods of making a nucleic acid encoding a human variable region Grant 9,708,635 - Murphy , et al. July 18, 2 | 2017-07-18 |
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20170137485 - GAVIN; Marc A. ;   et al. | 2017-05-18 |
Interleukin-2 muteins for the expansion of T-regulatory cells Grant 9,580,486 - Gavin , et al. February 28, 2 | 2017-02-28 |
Methods of modifying eukaryotic cells Grant 9,528,136 - Murphy , et al. December 27, 2 | 2016-12-27 |
Mice That Produce Hybrid Antibodies App 20160316731 - Murphy; Andrew J. ;   et al. | 2016-11-03 |
High Affinity Antibodies To Human Il-6 Receptor App 20160229916 - STEVENS; Sean ;   et al. | 2016-08-11 |
Methods of producing hybrid antibodies Grant 9,388,446 - Murphy , et al. July 12, 2 | 2016-07-12 |
Methods of producing hybrid antibodies Grant 9,382,567 - Murphy , et al. July 5, 2 | 2016-07-05 |
Methods of producing hybrid antibodies Grant 9,376,699 - Murphy , et al. June 28, 2 | 2016-06-28 |
Genetically modified mice that produce hybrid antibodies Grant 9,371,553 - Murphy , et al. June 21, 2 | 2016-06-21 |
Methods of producing hybrid antibodies Grant 9,353,394 - Murphy , et al. May 31, 2 | 2016-05-31 |
Method of treating rheumatoid arthritis with an anti-IL-6R antibody Grant 9,308,256 - Radin , et al. April 12, 2 | 2016-04-12 |
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20140343252 - GAVIN; Marc A. ;   et al. | 2014-11-20 |
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20140286898 - GAVIN; Marc A. ;   et al. | 2014-09-25 |
High Affinity Antibodies To Human Il-6 Receptor App 20140255995 - Stevens; Sean ;   et al. | 2014-09-11 |
Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody App 20140255390 - Radin; Allen ;   et al. | 2014-09-11 |
Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse Grant 8,791,323 - Murphy , et al. July 29, 2 | 2014-07-29 |
Methods of Modifying Eukaryotic Cells App 20140073010 - MURPHY; ANDREW J. ;   et al. | 2014-03-13 |
Methods of Modifying Eukaryotic Cells App 20140041068 - MURPHY; ANDREW J. ;   et al. | 2014-02-06 |
Methods of Modifying Eukaryotic Cells App 20140033336 - MURPHY; ANDREW J. ;   et al. | 2014-01-30 |
Methods of Modifying Eukaryotic Cells App 20140023637 - Murphy; Andrew J. ;   et al. | 2014-01-23 |
Methods of Modifying Eukaryotic Cells App 20140018522 - MURPHY; ANDREW J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140020125 - Murphy; Andrew J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140020124 - Murphy; Andrew J. ;   et al. | 2014-01-16 |
Methods for Modifying Eukaryotic Cells App 20140017782 - Murphy; Andrew J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140017238 - Murphy; Andrew J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140017229 - MURPHY; ANDREW J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140017781 - Murphy; Andrew J. ;   et al. | 2014-01-16 |
Methods of Modifying Eukaryotic Cells App 20140013457 - Murphy; Andrew J. ;   et al. | 2014-01-09 |
Method of treating rheumatoid arthritis with an anti-IL-6R antibody Grant 8,568,721 - Radin , et al. October 29, 2 | 2013-10-29 |
High Affinity Antibodies To Human Il-6 Receptor App 20130157313 - Stevens; Sean ;   et al. | 2013-06-20 |
Methods of using IL-1 antagonists to treat autoinflammatory disease Grant 8,414,876 - Mellis , et al. April 9, 2 | 2013-04-09 |
Method of Treating Rheumatoid Arthritis with an Anti-IL-6R Antibody App 20120258098 - Radin; Allen ;   et al. | 2012-10-11 |
Method of treating rheumatoid arthritis with an anti-IL-6R antibody Grant 8,192,741 - Radin , et al. June 5, 2 | 2012-06-05 |
High affinity antibodies to human IL-6 receptor Grant 8,183,014 - Stevens , et al. May 22, 2 | 2012-05-22 |
Method Of Treating Rheumatoid Arthritis With An Anti-il-6r Antibody App 20120045440 - Radin; Allen ;   et al. | 2012-02-23 |
High affinity human antibodies to human IL-18 receptor Grant 8,105,805 - Huang , et al. January 31, 2 | 2012-01-31 |
High Affinity Antibodies To Human Il-6 Receptor App 20120003697 - STEVENS; Sean ;   et al. | 2012-01-05 |
Methods Of Using Il-1 Antagonists To Treat Autoinflammatory Disease App 20110318342 - Mellis; Scott ;   et al. | 2011-12-29 |
Methods Of Using Il-1 Antagonists To Treat Familial Mediterranean Fever (fmf) App 20110311537 - MELLIS; SCOTT ;   et al. | 2011-12-22 |
Method of treating rheumatoid arthritis with an IL-6R antibody Grant 8,080,248 - Radin , et al. December 20, 2 | 2011-12-20 |
High Affinity Human Antibodies to Human IL-18 Receptor App 20110269187 - HUANG; TAMMY H. ;   et al. | 2011-11-03 |
Human antibodies to human IL-6 receptor Grant 8,043,617 - Stevens , et al. October 25, 2 | 2011-10-25 |
High affinity human antibodies to human IL-18 receptor Grant 8,003,103 - Huang , et al. August 23, 2 | 2011-08-23 |
Human antibodies to human IL-6 receptor App 20100316627 - Stevens; Sean ;   et al. | 2010-12-16 |
Method of Treating Rheumatoid Arthritis with an IL-6R Antibody App 20100316636 - Radin; Allen ;   et al. | 2010-12-16 |
Interferon-.alpha./.beta. binding fusion proteins and therapeutic uses thereof Grant 7,732,167 - Smith , et al. June 8, 2 | 2010-06-08 |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof Grant 7,666,622 - Sharma , et al. February 23, 2 | 2010-02-23 |
High Affinity Human Antibodies To Human Il-18 Receptor App 20100034833 - Huang; Tammy H. ;   et al. | 2010-02-11 |
High affinity human antibodies to human IL-18 receptor Grant 7,615,220 - Huang , et al. November 10, 2 | 2009-11-10 |
Interferon-.gamma. antagonists and therapeutic uses thereof Grant 7,608,430 - Karow , et al. October 27, 2 | 2009-10-27 |
High affinity antibodies to human IL-6 receptor Grant 7,582,298 - Stevens , et al. September 1, 2 | 2009-09-01 |
IL-18 specific polypeptides and therapeutic uses thereof Grant 7,557,084 - Karow , et al. July 7, 2 | 2009-07-07 |
Methods of Using IL-1 Antagonists to Treat Autoinflammatory Disease App 20090156492 - Mellis; Scott ;   et al. | 2009-06-18 |
Methods of using IL-1 antagonists to treat neointimal hyperplasia App 20080300181 - Wang; Li-Hsien ;   et al. | 2008-12-04 |
Methods of using IL-1 antagonists to treat autoinflammatory disease Grant 7,459,426 - Mellis , et al. December 2, 2 | 2008-12-02 |
IL-4/IL-13 specific polypeptides and therapeutic uses thereof Grant 7,410,781 - Karow , et al. August 12, 2 | 2008-08-12 |
VEGF-binding fusion proteins and nucleic acids encoding the same Grant 7,396,664 - Daly , et al. July 8, 2 | 2008-07-08 |
Use of an IL-1 antagonist for treating arthritis Grant 7,361,350 - Mellis , et al. April 22, 2 | 2008-04-22 |
High affinity antibodies to human IL-6 receptor App 20070280945 - Stevens; Sean ;   et al. | 2007-12-06 |
High affinity human antibodies to human IL-18 receptor App 20070237776 - Huang; Tammy H. ;   et al. | 2007-10-11 |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof App 20070087411 - Sharma; Prerna ;   et al. | 2007-04-19 |
Interferon-gamma antagonists and therapeutic uses thereof App 20070020283 - Karow; Margaret ;   et al. | 2007-01-25 |
Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof App 20060286641 - Smith; Eric ;   et al. | 2006-12-21 |
Methods of using IL-1 antagonists to reduce C-reactive protein App 20060171948 - Weinstein; Steven P. ;   et al. | 2006-08-03 |
High affinity fusion proteins and therapeutic and diagnostic methods for use Grant 7,083,950 - Stahl , et al. August 1, 2 | 2006-08-01 |
VEGF traps and therapeutic uses thereof App 20060058234 - Daly; Thomas J. ;   et al. | 2006-03-16 |
Methods of using IL-1 antagonists to treat autoinflammatory disease App 20050272655 - Mellis, Scott ;   et al. | 2005-12-08 |
IL-18 specific polypeptides and therapeutic uses thereof App 20050221433 - Karow, Margaret ;   et al. | 2005-10-06 |
SIRT6 transgenic non-human animals and assay methods App 20050204410 - Karow, Margaret ;   et al. | 2005-09-15 |
Use of an IL-1 antagonist for treating arthritis App 20050197293 - Mellis, Scott ;   et al. | 2005-09-08 |
IL-4/IL-13 specific polypeptides and therapeutic uses thereof App 20050191730 - Karow, Margaret ;   et al. | 2005-09-01 |
Modified ciliary neurotrophic factor polypeptides with reduced antigenicity App 20050069987 - Daly, Thomas J. ;   et al. | 2005-03-31 |
High affinity fusion proteins and therapeutic and diagnostic methods for use App 20050032175 - Stahl, Neil ;   et al. | 2005-02-10 |
Methods of using IL-1 antagonists to treat neointimal hyperplasia App 20040224893 - Wang, Li-Hsien ;   et al. | 2004-11-11 |
HIV-specific fusion proteins and therapeutic and diagnostic methods for use App 20040214285 - Glass, David J. ;   et al. | 2004-10-28 |
Chimeric molecules and novel assay system App 20010044135 - Stahi, Neil ;   et al. | 2001-11-22 |
NCAGE Code | 4BWM3 | KAROW MARGARET |
CAGE Code | 4BWM3 | KAROW, MARGARET |
DUNS | 619370948 | KAROW, MARGARET |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.